Global Risk Regime

A percentile-based risk regime view across US equities, volatility, credit, rates, and dollar pressure.

Regime score

58

Risk-offNeutralRisk-on

Neutral: selective exposure

Leadership is selective. Prefer confirmed participation over broad beta.

Data confidence93

2026.07.24 20:27 KST

Dashboard use standard

Dashboards are checklists, not conclusions.

TapeFlow dashboards split market regime, macro pressure, and sector flow into separate questions. Readers are not asked to follow one score; they can compare component indicators, latest dates, data confidence, and related radar views before sizing risk.

Component indicators and latest dates
Confidence and data gaps
Related radar and detail pages

Equity trend

+0.7%

S&P 500 1M, Nasdaq -1.3%

Percentile 39p2026-07-23

Volatility

18.7

VIX percentile. Lower is more risk-on.

Percentile 65p2026-07-23

Credit stress

3.44x

HY OAS / IG OAS. Lower means calmer credit.

Percentile 16p2026-07-22

Yield curve

0.36 pp

10Y-2Y. Higher is less cyclical stress.

Percentile 68p2026-07-22

Real rate

-0.10%

Fed Funds minus CPI YoY. Lower helps growth valuations.

Percentile 61p2026-06-01

Options sentiment

0.88

Put/call percentile. Lower means lighter hedging demand.

Percentile 55p2026-07-23

Leverage

+23.0%

FINRA margin debt 3-month change

Percentile --2026-06-30

Dollar pressure

-4.5%

USD/KRW 1M change. Higher is a risk-asset headwind.

Percentile 3p2026-07-24

Cross-asset tape

Equity trend vs risk pricing

Factor tape

Risk budget factor scores

Equity trend
39
Volatility
35
Credit stress
84
Yield curve
68
Real rate
39
Options sentiment
45
Leverage
--
Dollar pressure
97

US breadth

US Market Breadth

2026-07-24

NYSE breadth

NYSE

32.1 %

NASDAQ breadth

NASDAQ

32.7 %

AMEX breadth

AMEX

29.2 %

US new-high leadership

US 52-Week Highs + Turnover

2026-07-24

Crinetics Pharmaceuticals, Inc.

NASDAQ

$357M

Jazz Pharmaceuticals plc

NASDAQ

$135M

Apogee Therapeutics, Inc.

NASDAQ

$93M

Ultrapar Participacoes S.A. (New)

NYSE

$17M

US mega-cap concentration

US Mega-Cap Concentration

2026-07-24

Top 10 US Mega-Caps

US

25.5 %

NVIDIA Corporation

NASDAQ

4 %

Apple Inc.

NASDAQ

3.8 %

Alphabet Inc.

NASDAQ

3.1 %

Alphabet Inc. - Depositary Shares representing a 1/20th Interest in a Share of Series B Mandatory Convertible Preferred Stock

NASDAQ

3.1 %

Portfolio checklist

Above 68 with confidence above 80, favor trend and leadership exposure.

Below 38, stay defensive until at least two stress signals improve.

When confidence is low, verify freshness and missing inputs before sizing positions.